The Latest
-
Sorrento Therapeutics gets FDA approval for COVID-19 drug trial
-
Does Chegg (NYSE:CHGG) Have The Makings Of A Multi-Bagger?
-
Microsoft Q4 2020 earnings preview: It’s all about Azure
-
Tesla Is Said To Push For Record Q3 Deliveries; Shares Rise In Pre-Market